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Considering that nicotine instantly interacts with central and peripheral nervous systems promoting cardiovascular eﬀects after
tobacco smoking, we evaluated the modulation of glutamate, tyrosine hydroxylase (TH), neuropeptide Y (NPY), and substance P
(SP) in nodose/petrosal and superior cervical ganglia, as well as TH and NPY in nucleus tractus solitarii (NTS) and hypothalamic
paraventricular nucleus (PVN) of normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) after 8 weeks
of nicotine exposure. Immunohistochemical and in situ hybridization data demonstrated increased expression of TH in brain
and ganglia related to blood pressure control, preferentially in SHR, after nicotine exposure. The alkaloid also increased NPY
immunoreactivity in ganglia, NTS, and PVN of SHR, in spite of decreasing its receptor (NPY1R) binding in NTS of both strains.
Nicotine increased SP and glutamate in ganglia. In summary, nicotine positively modulated the studied variables in ganglia while
its central eﬀects were mainly constrained to SHR.
1.Introduction
Cardiovascular eﬀects of tobacco smoking are primarily
attributed to the presence of nicotine in cigarettes. This
alkaloid may promote decrease in baroreﬂex sensitivity,
increase in heart rate and blood pressure, atherosclerosis,
coronary heart disease, and myocardial infarction [1].
Nicotine potentiates sympathetic nervous system leading
toincreaseinplasmaandbraincatecholaminelevels[2,3].In
addition, we have previously demonstrated the acceleration
of onset and the exacerbation of hypertension in genetic
hypertension predisposed rats after nicotine exposure [4].
The activation of sympathetic neurotransmission by
nicotine may be based on its direct eﬀect on the central ner-
vous system, on sympathetic ganglia to increase the eﬀerent
nerve activity, and/or on peripheral sympathetic nerve end-
ings and adrenal medulla stimulating catecholamine release
[5]. Nevertheless, the activated sympathetic system might
promote the reﬂex parasympathetic response composing an
elaborated physiological eﬀect after nicotine administration.
The alkaloid instantly interacts with the central ner-
vous system binding to nicotinic acetylcholine receptors in
the hypothalamus, hippocampus, midbrain, and medulla
oblongata [6, 7] modulating norepinephrine, dopamine,
vasopressin, glutamate, neuropeptide Y (NPY), and other
neurotransmitter systems [8].
Nicotine acts also on chemoreceptors aﬀerents [9],
enteric nervous system [10], and visceral sensory aﬀerents
(for a review about nicotinic mechanisms in the autonomic
control of organ systems refer to De Biasi [11]).
Peripheral areas involved in cardiovascular control are
also under the inﬂuence of nicotine, such as the nodose/
petrosal ganglia [12]. It is well documented the presence2 International Journal of Hypertension
of several neurotransmitters such as NPY, substance P
(SP), catecholamines, and glutamate in nodose and petrosal
ganglia, which are related to baroreﬂex [13, 14]. Further-
more, baroreﬂex aﬀerents to nucleus tractus solitarii (NTS)
contain glutamate as the main neurotransmitter involved in
cardiovascular control, which may be regulated by several
other neurotransmitters such as catecholamines, NPY. and
SP.
Superior cervical ganglion is part of the sympathetic
chain located next to carotid bifurcation that participate
in generating the vasomotor tonus of head and neck [15].
The study of superior cervical ganglion is useful to evaluate
the function of sympathetic autonomic nervous system.
It is well established that the presence of the enzyme
tyrosine hydroxylase (TH) in this ganglion [16], which
participates in catecholamines synthesis, as well as NPY
and SP immunoreactive proﬁles and nicotinic acetylcholine
receptors [17] that may inﬂuence superior cervical ganglion
activity [18].
In view of this, the aim of the present study is to
evaluate the modulation of glutamate, TH, NPY, and SP in
nodose/petrosal and superior cervical ganglia and as well as
TH and NPY in nucleus tractus solitarii and hypothalamic
paraventricular nucleus of normotensive and spontaneously
hypertensiveratsafterprolongednicotineexposuredelivered
through subcutaneously implanted pellets.
2.MaterialandMethods
All the procedures and protocols were performed in accor-
dance with institutional and international guidelines for
animal care and use [19].
2.1. Animals and Nicotine Exposure. Male normotensive
Wistar Kyoto (WKY) and spontaneously hypertensive rats
(SHR), 1 month old, from the Institute of Biosciences,
University of S˜ ao Paulo (S˜ ao Paulo, Brazil), had either
nicotine or placebo pellets (Innovative Research of America,
Ohio) implanted subcutaneously during 8 weeks. Initially, 1-
month-old rats had 10mg/21 days pellets implanted in the
lateral side of their neck, which were replaced for pellets of
100mg/60 days until the end of treatment. Pellets released
nicotine continuously at the average rate of 8mg·kg−1·day−1
along treatment [20]. It was previously demonstrated that
exposure to this concentration of nicotine accelerated and
intensiﬁed the hypertension in SHR although the alkaloid
promoted no cardiovascular eﬀects in WKY rats [4].
Six rats of each strain and treatment were submitted
either to transcardiac perfusion for immunohistochemistry,
ordecapitationforbindinganalysisandinsituhybridization.
Brain, nodose/petrosal and cervical superior ganglia were
excised to the analysis of glutamate, tyrosine hydroxylase,
neuropeptide Y, and substance P.
2.2. Immunohistochemistry. Rats were deeply anaesthetized
andperfusedwith50mLofsaline(0.9%)followedby300mL
of a ﬁxative solution consisted of 4% paraformaldehyde
(w/v) and 0.2% picric acid (v/v) in 0.1mol/L PBS, pH 6.9,
at 4◦C.
Brainsections(14µm)wereobtainedinacryostat(Leica,
CM 3050, Germany) at rostrocaudal levels from −13.68 to
−14.08mm for the analysis of the NTS and at −1.80 to
−2.12mmtoaccessthePVNaccordingtotheatlasofPaxinos
and Watson [21]. Nodose/petrosal and superior cervical
ganglia were sectioned longitudinally.
Immunoreactivity was detected by the avidin-biotin per-
oxidase technique. Sections were incubated for 24 hours at
4◦C with rabbit polyclonal antisera against either glutamate
(1:2000, Sigma), TH (1:400, Eugene Tech), NPY (1:2000,
Sigma), or SP (1:1000, Peninsula) followed by incubation
with a biotinylated antirabbit immunoglobulin (1:230,
Vector, USA) for 90min. Sections were next incubated with
an avidin-biotin peroxidase complex (1:120, Vectastain,
Vector, USA) for 45min. Immunoreactivity was visualized
using 3-3 -diaminobenzidine tetrahydrochloride (DAB) as
chromogen and H2O2 (0.05%) after 6 minutes of reaction.
Immunoreactivities were analyzed by semiquantitative
microdensitometry,expressedasspMGV(speciﬁcmeangray
value), using a KS 400 image analyzer (Zeiss, Germany)
linked to a CCD 72 camera (Dage; MTI, Michigan City, Ind.,
USA) mounted on a Zeiss microscope (40x objective), as
previously described by Zoli and coworkers [22]. The value
for each animal was obtained by taking the mean of two
adjacent sections of each analyzed region.
2.3. In Situ Hybridization. Brain sections were obtained
as speciﬁed for immunohistochemistry and thaw-mounted
onto poly-L-lysine coated slides that were postﬁxed with
cold 4% parafolmaldehyde in phosphate buﬀered saline
(PBS) solution, dehydrated in ethanol and processed for
hybridization procedures.
Probes complementary to nucleotides 1351–1398 of TH
mRNA were employed for the detection of this mRNA
[23] and NPY was labeled with a probe corresponding to
nucleotides 3146–3194 of rat NPY mRNA [24].
Probes were synthesized by Life Technologies, labeled
with (35S)dATP using terminal deoxynucleotidyl transferase
(Roche, Germany) at the 3 -end, and puriﬁed according to
the previously described protocol [25]. Sections were incu-
bated overnight at 42◦C in a humidiﬁed chamber with the
labeledprobe(500000dpm/50µL/section)ina hybridization
buﬀer [25]. Slides containing the sections were extensively
rinsed in saline-sodium-citrate (SSC), dehydrated in ethanol
and exposed to a radioactivity sensitive ﬁlm (Kodak Biomax
MR, Kodak, USA) for four weeks. For control experiments,
radioactive probes were mixed with an excess (100x) of
nonradioactive probe.
Films were analyzed using a computer-assisted image
analyzerandsoftwaredevelopedbyImagingResearch(Brock
University, Canada).
2.4. Receptor Binding Analysis. NPY1R were evaluated in the
NTS and PVN through binding assay performed in the same
group of rat brains used for in situ hybridization.International Journal of Hypertension 3


























































































































































Figure 1: Immunoreactivity of tyrosine hydroxylase, neuropeptide Y, glutamate, and substance P in nodose/petrosal ganglia of Wistar Kyoto
(WKY)andspontaneouslyhypertensive(SHR)ratsexposedeithertonicotineorplacebodeliveredthroughsubcutaneouslyimplantedpellets
during 8 weeks. Values are presented as mean ± SD, ∗P<0.05 as compared to the same strain placebo treated rat; #P<0.05 as compared to
WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
NPY receptors were labeled with 0.25nM of (125I)PYY
(4000Ci/mmol, Amersham Biosciences) in a buﬀer con-
taining HEPES (20mM), NaCl (137mM), KCl (5.4mM),
KH2PO4 (0.44mM), CaCl2 (1.26mM), MgSO4 (0.81mM),
bacitracin (0.1%), and bovine serum albumin (BSA, 0.3%).
Ligand concentration, which is near to KD of NPY receptors,
was chosen based upon our previous results [26]. After
incubating for 60 minutes, sections were rinsed with trizma
50mM (pH 7.4) followed by distilled water, and exposed to
Biomax MR ﬁlm (Kodak) during 3 days.
Binding to NPY1R was calculated by displacing the
radioactive ligand with 10mM of NPY1R speciﬁc agonist
(leu31-Pro34) NPY (Peninsula).
2.5. Statistics. Results were evaluated by 2-way analysis
of variance (ANOVA) using GraphPad Prism (GraphPad
Software Inc., version 3.00, CA). A P value < 0.05 was
considered to indicate statistically signiﬁcant diﬀerences.
Values are shown as mean ± standard deviation (SD).
3. Results
3.1. Petrosal/Nodose Ganglia. Nicotine increased TH immu-
noreactivity by 40% only in SHR petrosal/nodose ganglia
as compared to placebo-treated SHR (Figure 1). However,
NPY, glutamate, and SP were increased in these ganglia of
both strains after chronic nicotine exposure, as compared
to placebo-treated rats (Figure 1). Moreover, SHR presented
increased levels of NPY and glutamate as compared to WKY
rats in absence of nicotine (Figure 1).
The results revealed an association between nicotine
exposition and the genetic background to increase TH im-
munoreactivity,suggestingtheinteractionamonggene,envi-
ronment, and physiology. The interaction of these parame-
ters was already previously demonstrated by our group when
the alkaloid exacerbated the hypertension in SHR while no
alteration in blood pressure was observed in the WKY [4].
In contrast, NPY and glutamate immunoreactivities depend






















































































































Figure 2: Immunoreactivity of tyrosine hydroxylase, neuropeptide Y, and substance P in superior cervical ganglion (SCG) of Wistar Kyoto
(WKY)andspontaneouslyhypertensive(SHR)ratsexposedeithertonicotineorplacebodeliveredthroughsubcutaneouslyimplantedpellets
during 8 weeks. Values are presented as mean ± SD, ∗P<0.05 as compared to the same strain placebo treated rat; #P<0.05 as compared to
WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
is inﬂuenced by nicotine, without the participation of the
genetic predisposition to hypertension.
3.2. Superior Cervical Ganglion. TH, NPY, and SP immun-
oreactivities were increased in SCG of SHR as com-
pared to WKY rats (Figure 2). Prolonged nicotine expo-
sure augmented the expression of these neurotransmit-
ters/modulators in both strains. Alteration in the expression
of these immunoreactivities were dependent on the interac-
tionbetweenratstrainandnicotinetreatment,sincetheSHR
presented elevated levels of these substances and nicotine
exacerbated them in SCG as can be observed in Figure 2.
3.3. TH Levels in NTS and PVN. TH immunoreactivity
and mRNA expression in the NTS did not diﬀer between
WKY and SHR rats without nicotine exposure. However,
the PVN of SHR presents 3.5x the amount of TH mRNA
of WKY rats (Figure 3), without any equivalent increase
in its immunoreactivity at basal levels. Nicotine increased
TH immunoreactivity and mRNA in the NTS of SHR
(Figures 3(a) and 3(b)). The alkaloid also increased TH
immunoreactivity in the PVN of both strains although TH
mRNA in this nucleus was not altered by nicotine exposure
(Figures 3(c) and 3(d)).
TH immunoreactivity and mRNA expression in the
NTS are inﬂuenced by the interaction between nicotine
exposure and rat strain, since only SHR responded to
nicotineexposure.Thismightbeofrelevanceconsideringthe
elevation of blood pressure exclusively in this strain. In the
PVN, TH mRNA is inﬂuenced by strain while the treatment
with nicotine is able to increase TH immunoreactivity,
without interference of rat strain.
3.4. NPY in NTS and PVN. SHR presented decreased levels
of NPY immunoreactivity in the NTS whereas NPY1R bind-
ing in this area is increased when compared to WKY (Figures
4(a) and 4(b)). In the presence of nicotine, NPY immunore-
activity increased in the NTS of SHR only while NPY1R
binding decreased 50% in this area of both strains (Figures
4(a) and 4(b)). NPY immunohistochemistry increased in the
PVNafterchronicnicotineexposureonlyinthehypertensiveInternational Journal of Hypertension 5





























































































































































Figure 3: Immunoreactivity and mRNA expression of tyrosine hydroxylase in the nucleus tractus solitarii (NTS) and paraventricular
hypothalamic nucleus (PVN) of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo
delivered through subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, ∗P<0.05 as compared to the same
strain placebo-treated rat; #P<0.05 as compared to WKY on the same experimental condition, according to 2-way ANOVA followed by
Bonferroni posttest, n = 6.
Table 1: Relative optical density (ROD, arbitrary units) of neu-
ropeptide Y mRNA radiolabeling in the nucleus tractus solitarii
(NTS) of spontaneously hypertensive (SHR) and Wistar Kyoto
(WKY) rats after prolonged exposure to nicotine or placebo
delivered through subcutaneously implanted pellets.
WKY Placebo 0.1053 ±0.0295
Nicotine 0.1035 ±0.0211
SHR Placebo 0.1174 ±0.0218
Nicotine 0.1130 ±0.0249
Values are presented as mean ± SD following 2-way-ANOVA (n = 6).
strain (Figures 4(c) and 4(d)). NPY1R binding is found
100%increasedinplaceboSHRascomparedtocontrolWKY
(Figure 4), nicotine seems not to modify binding parameters
in the PVN.
The interaction between rat strain and nicotine exposure
inﬂuenced NPY immunoreactivity in NTS and PVN. This
immunoreactivity is increased by nicotine only when the
genetic background of SHR is present. NPY1R binding in
NTS is aﬀected by rat strain and treatment with nicotine,
separately, since the amount of NPY1R binding is increased
in SHR and nicotine decreased it in the same magnitude in
both strains. NPY1R binding in the PVN is modulated only
by the rat strain. Nicotine had no eﬀect over this parameter.
NPY mRNA expression was not altered in SHR as compared
to WKY rats in either nuclei analyzed in the presence or
absence of nicotine (Table 1).
4. Discussion
In the present study we demonstrated that prolonged
nicotine administration through subcutaneously implanted
pellets increased TH immunoreactivity in brain and ganglia
related to blood pressure control, preferentially in SHR.
This is in agreement with our previous study that showed
the increased responsiveness of SHR to nicotine when
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Figure 4: Neuropeptide Y immunoreactivity and NPY1R binding in the nucleus tractus solitarii (NTS) and paraventricular hypothalamic
nucleus (PVN) of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo delivered through
subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, ∗P<0.05 as compared to the same strain placebo-
treatedrat; #P<0.05ascomparedtoWKYonthesameexperimentalcondition,accordingto2-wayANOVAfollowedbyBonferroniposttest,
n = 6.
immunoreactivity in ganglia, NTS, and PVN of SHR, in spite
of decreasing NPY1R binding in NTS of both strains. SP and
glutamate were increased in ganglia after nicotine prolonged
exposure.
The eﬀects of nicotine encountered at both central
and peripheral levels might be due to its action directly
upon the brain as well as on the sympathetic autonomic
nervous system and on smooth muscle of arterioles. It is
important to point out that a recent revision written by
Zanutto and collaborators [27] emphasized the long-term
blood pressure regulation also by the NTS in addition
to the renal mechanisms, which validate our study using
prolonged nicotine administration to analyze areas of central
cardiovascular control.
Glutamate immunoreactivity was evaluated only in
nodose/petrosal ganglia in the present study since the
analysis of this neurotransmitter in brain cardiovascular
areas was conducted previously by our group [4] and the
presence of glutamate as neurotransmitter in the SCG was
not described yet, although the expression of glutamate
receptors is found in SCG cells [28].
We have demonstrated an increase in glutamate immu-
noreactivity in nodose/petrosal ganglia of placebo SHR as
wellasafternicotineexposureinbothratstrainsascompared
to WKY control rats. The increased glutamate in the ganglia
might be released in the NTS by baroreceptor aﬀerents to
reduce blood pressure [29] since glutamate is a hypotensive
agent in this nucleus. Several studies have described the
sensitivity of neurons from petrosal and nodose ganglia
to nicotine [30–33] and it seems that a minor part of
barosensory neurons are responsive to nicotine [34]. In view
of this, the response observed in SHR may be due to the
raise in blood pressure, since the eﬀects of nicotine related
to glutamate immunoreactivity over the SHR were more
pronounced. Moreover, nicotine may act directly upon these
ganglia cells to determine integrated system responses.International Journal of Hypertension 7
Because the speciﬁcity of the ganglia neurons was not
investigated, the eﬀects of these immunoreactivities may be
also related to chemoreception [35], pain [36], interaction
with glial cells [37], and other physiological processes [38,
39].
NicotinealsoactsuponTHandNPYimmunoreactivities
in nodose/petrosal ganglia of SHR compared to WKY rat
ganglia which may be of relevance to the neural mechanisms
of blood pressure regulation. Since these molecules are
involved in the hypotensive response within the NTS it could
also be that the increase in TH and NPY immunoreactivities
are secondary in response to the raise in blood pressure
induced by nicotine. The possible eﬀects over neurotrans-
mission seem to be more pronounced in SHR that are more
responsive to the eﬀects of nicotine exposure [4].
On the other hand, increased TH and NPY immunore-
activities in sympathetic ganglia such as the superior cervical
ganglion may be indicative of increased activation of the
sympathetic nervous system, which ends up with the release
of norepinephrine into blood contributing to the develop-
ment of hypertension [40, 41].
The presence of substance P immunoreactivity in
nodose/petrosal ganglia is related to sensory aﬀerents from
ventricular myocardium [42], chemoreception [43, 44]a n d
it is released as a cotransmitter by baroreceptor aﬀerents
into the NTS where it may promote an increase in blood
pressure[45].Thepresentﬁndingsdemonstratedanincrease
in substance P expression in nodose/petrosal ganglia of both
strainsafternicotineexposurewhichindicatesadirectaction
of nicotine in these ganglia. As previously demonstrated
[4], nicotine did not increase blood pressure in WKY
rats, revealing the participation of substance P in complex
regulatory mechanisms other than only blood pressure
control.
At the SCG level, basal SP immunoreactivity level
was increased in SHR compared to WKY rats such as
previously demonstrated by Gurusinghe and Bell [46].
Nicotine treatment induced an additional increase in SP
immunoreactivity in the SHR, as observed with the other
transmitters, suggesting again a relation to the high blood
pressure level of this strain.
Matta and colleagues [47] demonstrated the ability of
peripherally administered nicotine to stimulate NPY and TH
expressionintheNTSandPVNassociatedwiththereleaseof
adrenocorticotropichormone.Thepresentstudycontributes
with the understanding of cardiovascular control associated
with nicotine abuse, since the results demonstrated the
increased responsiveness of hypertension genetic-susceptible
rats to nicotine considering NPY and TH, although the cause
and consequence remains to be further investigated.
Within the central nervous system, the results also
suggest an association between the direct eﬀects of nicotine
and a reﬂex response due to the increased blood pressure
of the SHR strain, an increased TH immunoreactivity
only in the NTS of SHR rats was observed. The analysis
of tyrosine hydroxylase possibly indicates the tentative of
homeostasis maintenance in response to blood pressure
elevation, as previously demonstrated by our group in a
model of experimental hypertension [48]. In contrast, we
demonstratedthatNPY1Rbindingisdecreasedafternicotine
exposure which may lead to increase in blood pressure as
described by Narvaez and colleagues [49].
TH mRNA and NPY1R binding are about 100%
increasedinthePVNofSHRregardlessofnicotineexposure.
This is in agreement with previous data that demonstrated
the increased sensitivity of SHR to stress related to aug-
mented NPY expression in brain [50]. Moreover, Yu and
Sharp [51] recently demonstrated the association between
noradrenergic regulation of the PVN neurons and the sensi-
tization to stress induced by nicotine administration, which
is in line with the present results considering the SHR strain.
In conclusion, ﬁndings of the present study suggest
that nicotine is able to modulate neurotransmitter systems
especially in peripheral ganglia, while its central eﬀects are
preferentially encountered in the SHR, which may be linked
to the elevation of blood pressure encountered in this strain.
Whether these eﬀects are direct or in response to alteration
in blood pressure remains to be determined.
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